- 全部删除
- 您的购物车当前为空
Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor and is mainly metabolized by glucuronidation. Nebicapone is mainly peripherally acting inhibitor that decreases the biotransformation of L-DOPA to 3-O-methyl-DOPA by inhibition of COMT. It is the potential for the treatment of Parkinson's disease.
为众多的药物研发团队赋能,
让新药发现更简单!
Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor and is mainly metabolized by glucuronidation. Nebicapone is mainly peripherally acting inhibitor that decreases the biotransformation of L-DOPA to 3-O-methyl-DOPA by inhibition of COMT. It is the potential for the treatment of Parkinson's disease.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,540 | 5日内发货 | |
5 mg | ¥ 2,610 | 5日内发货 | |
25 mg | ¥ 9,160 | 6-8周 | |
50 mg | ¥ 11,900 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | Nebicapone is a reversible catechol-O-methyltransferase (COMT) inhibitor and is mainly metabolized by glucuronidation. Nebicapone is mainly peripherally acting inhibitor that decreases the biotransformation of L-DOPA to 3-O-methyl-DOPA by inhibition of COMT. It is the potential for the treatment of Parkinson's disease. |
别名 | BIA 3-202 |
分子量 | 273.24 |
分子式 | C14H11NO5 |
CAS No. | 274925-86-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.